Bolt Biotherapeutics, Inc.
BOLT- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001641281
In the last 90 days, Bolt Biotherapeutics, Inc. insiders filed 2 open-market purchases and 3 sales; 23 institutions reported holding it in 13F filings for Q2 2026, worth $2.31M in total; no superinvestor holds it.
13F holders, Q1 2023
Institutional positions in Bolt Biotherapeutics, Inc. as of Mar 31, 2023. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 41
- −3 vs. Q4 2022
- Shares held
- 23.3M
- +2.70M (+13.1%) vs. Q4 2022
- Total value
- $32.4M
- +$5.63M (+21.0%) vs. Q4 2022
- New holders
- 4
- 13 more added
- Sold out
- 7
- 7 more reduced
Compare with Q4 2022: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting BOLT on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 23 | $2.31M |
| Q1 2026 | 24 | $2.49M |
| Q4 2025 | 21 | $3.30M |
| Q3 2025 | 24 | $4.28M |
| Q2 2025 | 25 | $5.10M |
| Q1 2025 | 30 | $7.33M |
| Q4 2024 | 38 | $9.99M |
| Q3 2024 | 32 | $12.2M |
| Q2 2024 | 37 | $17.0M |
| Q1 2024 | 39 | $33.6M |
| Q4 2023 | 40 | $27.0M |
| Q3 2023 | 35 | $25.5M |
| Q2 2023 | 40 | $32.1M |
| Q1 2023 | 41 | $32.4M |
| Q4 2022 | 44 | $26.8M |
| Q3 2022 | 56 | $39.7M |
| Q2 2022 | 62 | $54.8M |
| Q1 2022 | 66 | $79.3M |
| Q4 2021 | 62 | $164.6M |
| Q3 2021 | 72 | $449.1M |
| Q2 2021 | 61 | $513.8M |
| Q1 2021 | 70 | $1.04B |
Institutions, Q1 2023
Shares, value and share of portfolio for each institution holding Bolt Biotherapeutics, Inc.; share changes are against Q4 2022.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Salem Investment Counselors Inc | 40 | $56 | 0.00% | 00.0% | Unchanged |
| Barclays PLC | 147 | $204 | 0.00% | −1,528−91.2% | Reduced |
| Wells Fargo & Company | 151 | $210 | 0.00% | +2+1.3% | Added |
| Northwestern Mutual Wealth Management Co | 400 | $556 | 0.00% | 00.0% | Unchanged |
| Tower Research Capital LLC (TRC) | 3,972 | $5.00K | 0.00% | +1,755+79.2% | Added |
| Federated Hermes, Inc. | 3,739 | $5.20K | 0.00% | −290−7.2% | Reduced |
| Bank of America Corp | 11,780 | $16.4K | 0.00% | +10,982+1,376.2% | Added |
| Bank of New York Mellon Corp | 12,629 | $17.6K | 0.00% | 00.0% | Unchanged |
| Susquehanna International Group, LLP | 20,120 | $28.0K | 0.00% | −187−0.9% | Reduced |
| Prudential Financial Inc | 24,400 | $33.9K | 0.00% | 00.0% | Unchanged |
| Charles Schwab Investment Management Inc | 24,712 | $34.4K | 0.00% | +24,712 | New |
| Man Group plc | – | $35.3K | 0.00% | – | – |
| Bailard, Inc. | 28,500 | $39.6K | 0.00% | +28,500 | New |
| Northern Trust Corp | 31,182 | $43.3K | 0.00% | −1,097−3.4% | Reduced |
| State Street Corp | 48,737 | $67.7K | 0.00% | 00.0% | Unchanged |
| Bridgeway Capital Management, LLC | 75,200 | $104.5K | 0.00% | −112,400−59.9% | Reduced |
| FMR LLC | 78,433 | $109.0K | 0.00% | −60.0% | Reduced |
| Marquette Asset Management, LLC | 97,835 | $136.0K | 0.04% | 00.0% | Unchanged |
| Privium Fund Management (UK) Ltd | 116,516 | $150.3K | 0.12% | 00.0% | Unchanged |
| Velan Capital Investment Management LP | 140,000 | $194.6K | 0.17% | +140,000 | New |
| Geode Capital Management, LLC | 177,992 | $247.4K | 0.00% | +23,916+15.5% | Added |
| JPMorgan Chase & Co | 189,306 | $263.0K | 0.00% | +169,398+850.9% | Added |
| Assenagon Asset Management S.A. | 225,816 | $313.9K | 0.00% | 00.0% | Unchanged |
| Millennium Management LLC | 245,411 | $341.0K | 0.00% | +2,010+0.8% | Added |
| BlackRock Inc. | 274,430 | $381.5K | 0.00% | +1,317+0.5% | Added |
| Goldman Sachs Group Inc | 283,085 | $393.5K | 0.00% | +570.0% | Added |
| Morgan Stanley | 306,402 | $425.9K | 0.00% | +271,519+778.4% | Added |
| Hawkeye Capital Management, LLC | 415,039 | $576.9K | 0.97% | 00.0% | Unchanged |
| Renaissance Technologies LLC | 456,739 | $635.0K | 0.00% | +15,200+3.4% | Added |
| Adage Capital Partners GP, L.L.C. | 500,000 | $695.0K | 0.00% | +500,000 | New |
| Board of Trustees of The Leland Stanford Junior University | 719,546 | $1.00M | 0.09% | 00.0% | Unchanged |
| Vanguard Group Inc | 928,276 | $1.29M | 0.00% | 00.0% | Unchanged |
| Samsara BioCapital, LLC | 1,049,153 | $1.46M | 0.30% | 00.0% | Unchanged |
| Newtyn Management, LLC | 1,115,110 | $1.55M | 0.30% | −34,890−3.0% | Reduced |
| Nan Fung Group Holdings Ltd | 1,166,952 | $1.62M | 1.10% | 00.0% | Unchanged |
| OrbiMed Advisors LLC | 1,541,000 | $2.14M | 0.04% | +769,941+99.9% | Added |
| Tang Capital Management LLC | 1,627,553 | $2.26M | 0.34% | +1,227,553+306.9% | Added |
| Pivotal bioVenture Partners Investment Advisor LLC | 1,891,467 | $2.63M | 1.08% | 00.0% | Unchanged |
| Sofinnova Investments, Inc. | 2,754,437 | $3.83M | 0.26% | 00.0% | Unchanged |
| Citadel Advisors LLC | 2,838,445 | $3.95M | 0.00% | +86,283+3.1% | Added |
| Vivo Capital, LLC | 3,871,291 | $5.38M | 0.40% | 00.0% | Unchanged |
| Oasis Management Co Ltd. | 0 | $0 | 0.00% | −280,000−100.0% | Sold out |
| Russell Investments Group, Ltd. | 0 | $0 | 0.00% | −40,195−100.0% | Sold out |
| Eversept Partners, LP | 0 | $0 | 0.00% | −31,172−100.0% | Sold out |
| Ergoteles LLC | 0 | $0 | 0.00% | −28,507−100.0% | Sold out |
| Stifel Financial Corp | 0 | $0 | 0.00% | −14,014−100.0% | Sold out |
| Citigroup Inc | 0 | $0 | 0.00% | −43−100.0% | Sold out |
| Advisor Group Holdings, Inc. | 0 | $0 | 0.00% | −100−100.0% | Sold out |